A Comparative Open-Label Crossover Study of Respiratory-Gated Versus Non-Respiratory-Gated Transcutaneous Auricular Vagus Nerve Stimulation for the Treatment of Non-Motor Symptoms in Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2026

Study Completion Date

April 1, 2027

Conditions
Parkinson DiseaseApathySleep DisorderFatigueMood Disorders
Interventions
OTHER

Transcutaneous auricular vagus nerve stimulation

"Stimulation Target: Left cymba conchae.~25 Hz Non-Expiratory Gated taVNS: Stimulation is delivered for 30 seconds at a frequency of 25 Hz, followed by a 30-second interval.~25 Hz Expiratory Gated taVNS: One second of stimulation occurs during exhalation at a frequency of 25 Hz.~100 Hz Expiratory Gated taVNS: One second of stimulation is administered during exhalation at a frequency of 100 Hz."

Trial Locations (2)

230022

RECRUITING

Cognitive Neuropsychology Lab Anhui Medical University, Hefei

Unknown

RECRUITING

Cognitive Neuropsychology Lab Anhui Medical University, Hefei

All Listed Sponsors
lead

Anhui Medical University

OTHER